Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Lanzafame

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 18, 2021
Mini-review: Silico-tuberculosisMassimiliano Lanzafame, Sandro Vento
The Lancet. Oncology|June 1, 2011
Tuberculosis and cancer: a complex and dangerous liaisonSandro Vento, Massimiliano Lanzafame
Eclinicalmedicine|June 14, 2019
Patient-centered Care and Treatment in HIV InfectionMassimiliano Lanzafame, Sandro Vento
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 15, 2019
Tuberculosis-immune reconstitution inflammatory syndromeMassimiliano Lanzafame, Sandro Vento
The Journal of Antimicrobial Chemotherapy|March 26, 2009
Comment on: Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosisMassimiliano Lanzafame, Emanuela Lattuada, Fabiana Corsini
AIDS Patient Care and Stds|July 2, 2011
Efficacy of lopinavir-ritonavir reduced dose in HIV-infected patientsEmanuela Lattuada, Massimiliano Lanzafame, Sandro Vento
Frontiers in Medicine|October 31, 2025
HIV treatment default in sub-Saharan Africa: issues and possible solutionsSandro Vento, Mbi Mbi, Massimiliano Lanzafame
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 6, 2025
Delayed CD4 cell recovery in HIV-associated disseminated nontuberculous mycobacterial diseaseSandro Vento, Massimiliano Lanzafame, Alfredo Vallone
Biomedicines|February 26, 2025
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a CureMassimiliano Lanzafame, Giovanni Mori, Sandro Vento
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2019
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator DrugMassimiliano Lanzafame, Emanuela Lattuada, Sandro Vento
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 18, 2021
Mini-review: Silico-tuberculosisMassimiliano Lanzafame, Sandro Vento
The Lancet. Oncology|June 1, 2011
Tuberculosis and cancer: a complex and dangerous liaisonSandro Vento, Massimiliano Lanzafame
Eclinicalmedicine|June 14, 2019
Patient-centered Care and Treatment in HIV InfectionMassimiliano Lanzafame, Sandro Vento
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 15, 2019
Tuberculosis-immune reconstitution inflammatory syndromeMassimiliano Lanzafame, Sandro Vento
The Journal of Antimicrobial Chemotherapy|March 26, 2009
Comment on: Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosisMassimiliano Lanzafame, Emanuela Lattuada, Fabiana Corsini
AIDS Patient Care and Stds|July 2, 2011
Efficacy of lopinavir-ritonavir reduced dose in HIV-infected patientsEmanuela Lattuada, Massimiliano Lanzafame, Sandro Vento
Frontiers in Medicine|October 31, 2025
HIV treatment default in sub-Saharan Africa: issues and possible solutionsSandro Vento, Mbi Mbi, Massimiliano Lanzafame
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 6, 2025
Delayed CD4 cell recovery in HIV-associated disseminated nontuberculous mycobacterial diseaseSandro Vento, Massimiliano Lanzafame, Alfredo Vallone
Biomedicines|February 26, 2025
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a CureMassimiliano Lanzafame, Giovanni Mori, Sandro Vento
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2019
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator DrugMassimiliano Lanzafame, Emanuela Lattuada, Sandro Vento
Pageof 12